Skip to main content
. 2020 Aug;9(4):1169–1179. doi: 10.21037/tlcr-19-686

Figure 1.

Figure 1

Kaplan-Meier curves of survival in the entire cohort of nivolumab treated MPM patients (median follow-up time of 10.1 months). (A) Progression-free survival in the entire cohort; (B) overall survival in the entire cohort. PFS, progression-free survival; OS, overall survival.